PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.\', \'Emmes Company, Rockville, MD 20850, USA.\', \'Moderna, Inc., Cambridge, MA 02139, USA.\', \'Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.\', \'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abj4176
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34385356
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34385356>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34385356>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all